Tenaya Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Tenaya Therapeutics, Inc. (TNYA) had Operating Lease, Liability, Noncurrent of $1.07 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Noncurrent $1.07M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $7.00M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $7.81M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $8.60M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $7.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $7.81M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $8.60M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $9.38M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $10.12M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $10.83M 10-K · filed 2026-03-11 |
| 2024-09-30 | $11.53M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $12.21M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $7.30M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $8.11M 10-K · filed 2025-03-10 |
| 2023-09-30 | $8.89M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $9.66M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $10.39M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $11.09M 10-K · filed 2024-03-18 |
| 2022-09-30 | $12.04M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $13.10M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $13.09M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $13.71M 10-K · filed 2023-03-08 |
| 2021-09-30 | $14.31M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $14.89M 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |